×

Home | Products | Interventional Cardiology

Interventional Cardiology

RenalGuard TherapyŽ is designed to reduce the toxic effects that contrast media can have on the kidneys, which may lead to a reduction in the incidence of Contrast-Induced Nephropathy (CIN) in at-risk patients. This therapy is based on existing published literature, including the PRINCE study1, which support the theory that creating and maintaining a high urine output through the kidneys allows the body to rapidly eliminate contrast, reducing its toxic effects.


Advanced Search

Supplier :
Therapy Area :
Sub Therapy Area :
Regional :
Featured :
Yes
No
Both
Keyword :

Ordering :
Results :